Modulation of inflammatory and metastatic processes

Details for Australian Patent Application No. 2005216904 (hide)

International Classifications

Event Publications

7 September 2006 PCT application entered the National Phase

PCT publication WO2005/082340 Priority application(s): WO2005/082340

26 June 2008 Assignment before Grant

Chiron Corporation The application has been assigned to Novartis Vaccines and Diagnostics, Inc.

5 November 2009 Alteration of Name

The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.

25 November 2010 Application Accepted

Published as AU-B-2005216904

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.